Amyris Inc. (NASDAQ: AMRS) stock jumped 22.11% on Friday to $2.32 against a previous-day closing price of $1.90. With 11.89 million shares changed hands, the volume of the stock remained heavier than its average volume of 6.69 million shares. During the session, the Specialty Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $2.3200 whereas the lowest price it dropped to was $1.9200. The 52-week range on AMRS shows that it touched its highest point at $16.31 and its lowest point at $1.47 during that stretch. It currently has a 1-year price target of $11.76. Beta for the stock currently stands at 1.60.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AMRS was up-trending over the past week, with a rise of 24.06%, but this was up by 0.87% over a month. Three-month performance dropped to -29.27% while six-month performance fell -43.00%. The stock lost -84.04% in the past year, while it has lost -57.12% so far this year. A look at the trailing 12-month EPS for AMRS yields -0.30 with Next year EPS estimates of -0.40.
Float and Shares Shorts:
At present, 312.90 million AMRS shares are outstanding with a float of 224.67 million shares on hand for trading. On Jul 14, 2022, short shares totaled 46.04 million, which was 14.40% higher than short shares on Jun 14, 2022. In addition to Mr. John G. Melo as the firm’s Pres, CEO & Director, Mr. Hermanus Kieftenbeld serves as its CFO & Chief Admin. Officer.
Through their ownership of 49.09% of AMRS’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 49.88% of AMRS, in contrast to 24.71% held by mutual funds. Shares owned by individuals account for 17.60%. As the largest shareholder in AMRS with 5.30% of the stake, Farallon Capital Management LLC holds 16,931,427 shares worth 16,931,427. A second-largest stockholder of AMRS, The Vanguard Group, Inc., holds 16,909,833 shares, controlling over 5.29% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in AMRS, holding 10,807,917 shares or 3.38% stake. With a 2.98% stake in AMRS, the BlackRock Innovation and Growth T is the largest stakeholder. A total of 9,535,672 shares are owned by the mutual fund manager. The Vanguard Total Stock Market Index, which owns about 1.91% of AMRS stock, is the second-largest Mutual Fund holder. It holds 6,117,706 shares valued at 12.74 million. Vanguard Small Cap Index Fund holds 1.65% of the stake in AMRS, owning 5,282,904 shares worth 11.0 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AMRS since 8 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AMRS analysts setting a high price target of $22.00 and a low target of $2.50, the average target price over the next 12 months is $11.76. Based on these targets, AMRS could surge 848.28% to reach the target high and rise by 7.76% to reach the target low. Reaching the average price target will result in a growth of 406.9% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. AMRS will report FY 2022 earnings on 02/28/2023. Analysts have provided yearly estimates in a range of -$0.56 being high and -$1.25 being low. For AMRS, this leads to a yearly average estimate of -$0.85. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Amyris Inc. surprised analysts by -$0.10 when it reported -$0.34 EPS against a consensus estimate of -$0.24. The surprise factor in the prior quarter was $0.34. Based on analyst estimates, the high estimate for the next quarter is -$0.10 and the low estimate is -$0.40. The average estimate for the next quarter is thus -$0.29.
Summary of Insider Activity:
Insiders traded AMRS stock several times over the past three months with 3 Buys and 7 Sells. In these transactions, 60,000 shares were bought while 199,225 shares were sold. The number of buy transactions has increased to 24 while that of sell transactions has risen to 12 over the past year. The total number of shares bought during that period was 4,022,472 while 255,421 shares were sold.